Company intelligence / Profile preview
Noveome Biotherapeutics
Pittsburgh, Pennsylvania, United Statesnoveome.com ↗
- Ownership
- Private
- Development stage
- Phase 2
01
Overview
Noveome’s lead product ST266 has demonstrated safety and biologic activity in both preclinical and clinical studies. A completed Phase 2 trial showed benefit in healing persistent corneal epithelial defects. Ongoing or recently completed trials include Phase 1 studies for intravenous administration in COVID-related cytokine storm/sepsis and intranasal delivery for neuroprotection. No serious adverse events have been reported across more than 235 patients dosed in nine clinical trials to date.
- Therapeutic areas
- OphthalmologyImmunologyDermatologyNeurology
- Modalities
- Cell-free secretome/biologic (multi-targeted secretome containing hundreds of biologically active proteins and factors derived from amnion-derived epithelial cells)
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Walter Reed Army Institute of Research (collaboration on traumatic brain injury models)Lancet Capital consortium including UPMC Enterprises, Highmark Blue Cross/Blue Shield, University of Pittsburgh & Carnegie Mellon University as early funders/investors
Beyond the preview
Go deeper on Noveome Biotherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Noveome Biotherapeutics.